Preclinical study of fusogenic vaccinia virus armed with immunostimulatory genes in orthotopic pancreatic cancer models

被引:0
|
作者
Ishiguro, Ryo [1 ,2 ]
Nakatake, Motomu [2 ]
Kurosaki, Hajime [2 ]
Nakagawa, Moe [2 ]
Takahashi, Mami [3 ]
Fujiwara, Yoshiyuki [1 ]
Nakamura, Takafumi
机构
[1] Univ Tottori, Div Gastrointestinal & Pediat Surg, Tottori, Japan
[2] Univ Tottori, Div Genom Med, Tottori, Japan
[3] Natl Canc Ctr, Cent Anim Div, Res Inst, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-2300
引用
收藏
页码:1209 / 1209
页数:1
相关论文
共 50 条
  • [31] Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
    Mengyuan Li
    Minghuan Zhang
    Qian Ye
    Yunhua Liu
    Wenbin Qian
    Cancer Biology & Medicine, 2023, (09) : 646 - 661
  • [32] Preclinical and clinical trials of oncolytic vaccinia virus in cancer immunotherapy: a comprehensive review
    Mengyuan Li
    Minghuan Zhang
    Qian Ye
    Yunhua Liu
    Wenbin Qian
    Cancer Biology & Medicine, 2023, 20 (09) : 646 - 661
  • [33] GEMMs as preclinical models for testing pancreatic cancer therapies
    Gopinathan, Aarthi
    Morton, Jennifer P.
    Jodrell, Duncan I.
    Sansom, Owen J.
    DISEASE MODELS & MECHANISMS, 2015, 8 (10) : 1185 - 1200
  • [34] The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
    Ling, Qiaoyun
    Zheng, Bichun
    Chen, Xudong
    Ye, Shaoshun
    Cheng, Quan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [35] Construction of orthotopic xenograft mouse models for human pancreatic cancer
    Dai, Lei
    Lu, Caide
    Yu, Xi
    Dai, Long-Jun
    Zhou, Jeff X.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (03) : 1033 - 1038
  • [36] Preclinical Toxicology Assessment of an Oncolytic Measles Virus Armed with H. pylori Immunostimulatory Bacterial Antigen in Preparation for a Phase I Trial in Breast Cancer Patients
    Viker, Kimberly
    Steele, Michael B.
    Iankov, Ianko D.
    Ammayappan, Arun
    Concilio, Susanna C.
    Bolon, Brad
    Jenks, Nathan J.
    Panagioti, Eleni
    Federspiel, Mark J.
    Liu, Minetta C.
    Peng, Kah Whye
    Galanis, Evanthia
    MOLECULAR THERAPY, 2021, 29 (04) : 5 - 5
  • [37] A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics
    Katz, MH
    Takimoto, S
    Spivack, D
    Moossa, AR
    Hoffman, RM
    Bouvet, M
    JOURNAL OF SURGICAL RESEARCH, 2003, 113 (01) : 151 - 160
  • [38] AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer
    Yu, Jianlei
    An, Nan
    Zhu, Jili
    Zhu, Borong
    Zhang, Guohui
    Chen, Kan
    Zhou, Yanrong
    Ye, Ting
    Li, Gongchu
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (04):
  • [39] A comparative study of patient-derived tumor models in pancreatic cancer employing orthotopic transplantation
    Iino, Yuki
    Yanagihara, Kazuyoshi
    Yokozaki, Hiroshi
    Kubo, Takanori
    Kubo, Takashi
    Komatsu, Masayuki
    Sasaki, Hiroki
    Ichikawa, Hitoshi
    Kuwata, Takeshi
    Seyama, Toshio
    Ochiai, Atsushi
    CANCER SCIENCE, 2022, 113 : 478 - 478
  • [40] Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer
    Espey, Michael Graham
    Chen, Ping
    Chalmers, Brian
    Drisko, Jeanne
    Sun, Andrew Y.
    Levine, Mark
    Chen, Qi
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (11) : 1610 - 1619